Literature DB >> 1080789

The ontogeny of antigen-specific T cells.

A M Silverstein, S Segal.   

Abstract

Although the fetal lamb is unable to form circulating antiovalbumin antibodies until about 120 days of gestation, ovalbumin-specific helper T cells can be stimulated to function at an earlier age. This would suggest that the critical event responsible for the precise sequential maturation of immunologic competence to different antigens at different developmental stages is not the first appearance of specific receptors on immunocytes. Alternative explanations of this phenomenon are discussed.

Mesh:

Substances:

Year:  1975        PMID: 1080789      PMCID: PMC2189928          DOI: 10.1084/jem.142.3.802

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  Presence of antigen-binding cells for five diverse antigens at the onset of lymphoid development: lack of evidence for somatic diversification during ontogeny.

Authors:  J M Decker; J Clarke; L M Bradley; A Miller; E E Sercarz
Journal:  J Immunol       Date:  1974-12       Impact factor: 5.422

2.  Development of humoral immunity in lethally irradiated mice reconstituted with fetal liver.

Authors:  W K Sherwin; D T Rowlands
Journal:  J Immunol       Date:  1974-10       Impact factor: 5.422

3.  Acquired immunity in opossum (Didelphis virginiana) embryos.

Authors:  D T Rowlands; D Blakeslee; E Angala
Journal:  J Immunol       Date:  1974-06       Impact factor: 5.422

4.  Early simultaneous appearance of antigen binding cells in the foetal sheep.

Authors:  J M Decker; E E Sercarz
Journal:  Nature       Date:  1974-11-29       Impact factor: 49.962

5.  Assay of anti-hapten antibody with the aid of hapten-coupled bacteriophage.

Authors:  O Mäkelä
Journal:  Immunology       Date:  1966-01       Impact factor: 7.397

6.  Ontogeny of mouse lymphocyte function. II. Development of the ability to produce antibody is modulated by T lymphocytes.

Authors:  D E Mosier; B M Johnson
Journal:  J Exp Med       Date:  1975-01-01       Impact factor: 14.307

7.  Fetal response to antigenic stimulus. II. Antibody production by the fetal lamb.

Authors:  A M SILVERSTEIN; J W UHR; K L KRANER; R J LUKES
Journal:  J Exp Med       Date:  1963-05-01       Impact factor: 14.307

8.  The requirement of more than one antigenic determinant for immunogenicity.

Authors:  K Rajewsky; V Schirrmacher; S Nase; N K Jerne
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

9.  Carrier function in anti-hapten immune responses. I. Enhancement of primary and secondary anti-hapten antibody responses by carrier preimmunization.

Authors:  D H Katz; W E Paul; E A Goidl; B Benacerraf
Journal:  J Exp Med       Date:  1970-08-01       Impact factor: 14.307

10.  In vitro induction of a primary response to the dinitrophenyl determinant.

Authors:  S Segal; A Globerson; M Feldman; J Haimovich; M Sela
Journal:  J Exp Med       Date:  1970-01-01       Impact factor: 14.307

  10 in total
  5 in total

Review 1.  Technologies for enhanced efficacy of DNA vaccines.

Authors:  Fadi Saade; Nikolai Petrovsky
Journal:  Expert Rev Vaccines       Date:  2012-02       Impact factor: 5.217

Review 2.  DNA vaccines: safety and efficacy issues.

Authors:  D M Klinman; M Takeno; M Ichino; M Gu; G Yamshchikov; G Mor; J Conover
Journal:  Springer Semin Immunopathol       Date:  1997

3.  Induction of neonatal tolerance by plasmid DNA vaccination of mice.

Authors:  G Mor; G Yamshchikov; M Sedegah; M Takeno; R Wang; R A Houghten; S Hoffman; D M Klinman
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

4.  Ontogeny of B-lymphocyte function. IX. Difference in the time of maturation of the capacity of B lymphocytes from foetal and neonatal mice to produce a heterogeneous antibody response to thymic-dependent and thymic-independent antigens.

Authors:  D H Sherr; M R Szewczuk; A Cusano; W Rappaport; G W Siskind
Journal:  Immunology       Date:  1979-04       Impact factor: 7.397

5.  Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives.

Authors:  Yingying Xu; Pak-Wai Yuen; Jenny Ka-Wing Lam
Journal:  Pharmaceutics       Date:  2014-07-10       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.